Mice lacking TNFα receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody

Cell Death and Differentiation

Volumn 10, Issue 9, 2003, Pages 997-1004

  Costelli, Paola ^a   Aoki, P ^b   Zingaro, B ^c   Carbo N ^d   Reffo, P ^a   Lopez Soriano, F J ^d   Bonelli, G ^a   Argiles J M ^d   Baccino, F M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c Dipartimento di Patologia Clinica   (Italy)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; Fas; Knockout mice; TNF; TNF receptors

Indexed keywords

CALPAIN; CASPASE 3; CASPASE 8; CASPASE 9; CATHEPSIN B; DNA FRAGMENT; FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEINASE; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; ANTIBODY; FASL PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; APOPTOSIS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; IMMUNOPATHOLOGY; LIVER CELL; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; WILD TYPE; ANIMAL; ANIMAL HEPATITIS; ARTICLE; C57BL MOUSE; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALIA;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; HEPATITIS, ANIMAL; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042914348     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401281     Document Type: Review

References (55)

1. Desbarats J and Newell MK (2000) Fas engagement accelerates liver regeneration after partial hepatectomy. Nat. Med. 6: 920-923.
2. Tran SE, Holmstrom TH, Ahonen M, Kahari VM and Eriksson JE (2001) MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 276: 16484-16490.
3. Budd RC (2002) Death receptors couple to both cell proliferation and apoptosis. J. Clin. Invest. 109: 437-441.
4. Nagata S and Golstein P (1995) The Fas death factor. Science 267: 1449-1456.
5. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687.
6. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH and Peter ME (1999) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274: 22532-22538.
7. Pinkoski MJ, Brunner T, Green DR and Lin T (2000) Fas and Fas ligand in gut and liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G354-G366.
8. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH and Runkel L (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182: 1223-1230.
9. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H and Kamada T (1994) Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19: 1354-1359.
10. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, Fusamoto H and Kamada T (1996) Fas antigen expression in liver tissues of patients with chronic hepatitis B. J. Hepatol. 24: 1-7.
11. Kondo T, Suda T, Fukuyama H, Adachi M and Nagata S (1997) Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3: 409-413.
12. Seishima M, Takemura M, Saito K, Ando K and Noma A (1997) Increased serum soluble Fas (sFas) concentrations in HCV-positive patients with liver cirrhosis. J. Hepatol. 27: 424-425.
13. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J and Nagata S (1994) Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res. 215: 332-337.
14. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T and Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809.
15. Ledgerwood EC, Pober JS and Bradley JR (1999) Recent advances in the molecular basis of TNF signal transduction. Lab. Invest. 79: 1041-1050.
16. Rolfe M, James NH and Roberts RA (1997) Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis 18: 2277-2278.
17. Xu Y, Jones BE, Neufeld DS and Czaja MJ (1998) Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor toxicity. Gastroenterology 115: 1229-1237.
18. Michalopoulos GK and DeFrances MC (1997) Liver regeneration. Science 276: 60-66.
19. Takehara T, Hayashi N, Mita E, Kanto T, Tatsumi T, Sasaki Y, Kasahara A and Hori M (1998) Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNF alpha. Hepatology 27: 1643-1651.
20. Yamada Y and Fausto N (1998) Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol. 152: 1577-1589.
21. Rose ML, Bradford BU, Germolec DR, Lin M, Tsukamoto H and Thurman RG (2001) Gadolinium chloride-induced hepatocyte proliferation is prevented by antibodies to tumor necrosis factor alpha. Toxicol. Appl. Pharmacol. 170: 39-45.
22. Tiegs G, Wolter M and Wendel A (1989) Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 38: 627-631.
23. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, Niwa M, Senoh H and Fujiwara H (1994) T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179: 1529-1537.
24. Bradham CA, Plumpe J, Manns MP, Brenner DA and Trautwein C (1998) Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Physiol. 275: G387-G392.
25. Plumpe J, Malek NP, Bock CT, Rakemann T, Manns MP and Trautwein C (2000) NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G173-G183.
26. Jones BE, Lo CR, Liu H, Pradhan Z, Garcia L, Srinivasan A, Valentino KL and Czaja MJ (2000) Role of caspases and NF-kappaB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G693-G699.
27. Czaja MJ (2001) TNF toxicity - death from caspase or cathepsin, that is the question. Hepatology 34: 844-846.
28. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG and Wendel A (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146: 1220-1234.
29. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Ruckert R, Krause H and Kunzendorf U (1997) Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3: 1124-1128.
30. Bulfone-Paus S, Bulanova E, Pohl T, Budagian V, Durkop H, Ruckert R, Kunzendorf U, Paus R and Krause H (1999) Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J. 13: 1575-1585.
31. Wenner GA, Mica L, Wanner-Schmid E, Kolb SA, Hentze H, Trentz O and Ertel W (1999) Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity. FASEB J. 13: 1239-1248.
32. Hoglen NC, Hirakawa BP, Fisher CD, Weeks S, Srinivasan A, Wong AM, Valentino KL, Tomaselli KJ, Bai X, Karanewsky DS and Contreras PC (2001) Characterization of the caspase inhibitor IDN-1965 in a model of apoptosis-associated liver injury. J. Pharmacol. Exp. Ther. 297: 811-818.
33. Ruiz-Vela A, Gonzalez de Buitrago G and Martinez-A C (1999) Implication of calpain in caspase activation during B cell clonal deletion. EMBO J. 18: 4988-4998.
34. Chen M, He H, Zhan S, Krajewski S, Reed JC and Gottlieb RA (2001) Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J. Biol. Chem. 276: 30724-30728.
35. Varghese J, Radhika G and Sarin A (2001) The role of calpain in caspase activation during etoposide induced apoptosis in T cells. Eur. J. Immunol. 31: 2035-2041.
36. Ding WX, Shen HM and Ong CN (2002) Calpain activation after mitochondrial permeability transition in microcystin-induced cell death in rat hepatocytes. Biochem. Biophys. Res. Commun. 291: 321-331.
37. Deiss LP, Galinka H, Berissi H, Cohen O and Kimchi A (1996) Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15: 3861-3870.
38. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M and Jaattela M (2001) Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153: 999-1010.
39. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH and Gores GJ (2000) Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106: 1127-1137.
40. Spanaus KS, Schlapbach R and Fontana A (1998) TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur. J. Immunol. 28: 4398-4408.
41. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V and Kahn A (1996) Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2: 80-86.
42. Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S and Vassalli P (1996) A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 183: 1031-1036.
43. Mukherjee D, Kaestner KH, Kovalovich KK and Greenbaum LE (2001) Fas-induced apoptosis in mouse hepatocytes is dependent on C/EBPbeta. Hepatology 33: 1166-1172.
44. Chung JY, Park YC, Ye H and Wu H (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115: 679-688.
45. Matsuki Y, Li L, Hsu HC, Yang PA, Zheng R, Edwards III CK, Chaudry IH, Zhang HG and Mountz JD (2002) Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells. Cell Death Differ. 9: 626-635.
46. Rai RM, Zhang JX, Clemens MG and Diehl AM (1996) Gadolinium chloride alters the acinar distribution of phagocytosis and balance between pro- and anti-inflammatory cytokines. Shock 6: 243-247.
47. Rai RM, Loffreda S, Karp CL, Yang SQ, Lin HZ and Diehl AM (1997) Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology 25: 889-895.
48. Yonehara S, Ishii A and Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747-1756.
49. Teh HS, Seebaran A and Teh SJ (2000) TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death. J. Immunol. 165: 4814-4821.
50. Varfolomeev EE, Boldin MP, Goncharov TM and Wallach D (1996) A potential mechanism of 'cross-talk' between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other. J. Exp. Med. 183: 1271-1275.
51. Bang S, Jeong EJ, Kim IK, Jung YK and Kim KS (2000) Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction. J. Biol. Chem. 275: 36217-36222.
52. Kim BC, Kim HT, Mamura M, Ambudkar IS, Choi KS and Kim SJ (2002) Tumor necrosis factor induces apoptosis in hepatoma cells by increasing Ca(2+) release from the endoplasmic reticulum and suppressing Bcl-2 expression. J. Biol. Chem. 277: 31381-31389.
53. Kalb A, Bluethmann H, Moore MW and Lesslauer W (1996) Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J. Biol. Chem. 271: 28097-28104.
54. Kaufmann SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49: 5870-5878.
55. Lowry OH, Rosebrough NJ, Farr AL and Randall (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.